Jpmorgan Chase & CO Liva Nova PLC Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LIVN
# of Institutions
256Shares Held
55.9MCall Options Held
566KPut Options Held
506K-
Black Rock Inc. New York, NY6.9MShares$338 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.98MShares$293 Million0.24% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$136 Million0.07% of portfolio
-
State Street Corp Boston, MA2.05MShares$100 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$91.5 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.62B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...